Atlas Trials

A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)

Clinical trial NCT05295173 · COMPLETED

Trial details

NCT number
NCT05295173
Sponsor
Angde Biotech Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2022-03-21
Primary completion
2023-06-22
Enrollment
1412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.